Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

Journal of Clinical Oncology

Volumn 24, Issue 1, 2006, Pages 181-189

  Li, Ye Xiong ^a   Yao, Bo ^a   Jin, Jing ^a   Wang, Wei Hu ^a   Liu, Yue Ping ^a   Song, Yong Wen ^a   Wang, Shu Lian ^a   Liu, Xin Fan ^a   Zhou, Li Qiang ^a   He, Xiao Hui ^a   Lu, Ning ^a   Yu, Zi Hao ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCHOOL CHILD; T CELL LYMPHOMA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; ARTICLE; CHILD; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; NOSE NEOPLASMS; PROGNOSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33644835980     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.2573     Document Type: Review

References (66)

1. Ribrag V, Ell Hajj M, Janot F, et al: Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 15:1123-1126, 2001
2. Savage KJ, Chhanabhai M, Gascoyne RD, et al: Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 15:1467-1475, 2004
3. Grau C, Jakobsen MH, Harbo G, et al: Sino-nasal cancer in Denmark 1982-1991: A nationwide survey. Acta Oncol 40:19-23, 2001
4. Quraishi MS, Bessell EM, Clark DM, et al: Aggressive sino-nasal non-Hodgkin's lymphoma diagnosed in Nottinghamshire, UK, between 1987 and 1996. Clin Oncol (R Coll Radiol) 13:269-272, 2001
5. Cuadra-Garcia I, Proulx GM, Wu CL, et al: Sinonasal lymphoma: A clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 23:1356-1369, 1999
6. Rodriguez J, Romaguera JE, Manning J, et al: Nasal-type T/NK cell lymphomas: A clinicopathologic study of 13 cases. Leuk Lymphoma 39:139-144, 2000
7. Li YX, Coucke PA, Li JY, et al: Primary non-Hodgkin's lymphoma of the nasal cavity: Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83:449-456, 1998
8. Liang R, Todd D, Chan TK, et al: Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 13:666-670, 1995
9. Zhang XJ, Jiang GL, Cao JN: Combined radiotherapy and chemotherapy for nasal non-Hodgkin's lymphoma. Chin J Radiat Oncol 9:162-165, 2000
10. Hu WH, Chen M, Sun Y, et al: Multivariate prognostic analysis of stage I(E) primary non-Hodgkin's lymphomas of the nasal cavity. Am J Clin Oncol 24:286-289, 2001
11. Aviles A, Diaz NR, Neri N, et al: Angiocentric nasal T/natural killer cell lymphoma: A single center study of prognostic factors in 108 patients. Clin Lab Haematol 22:215-220, 2000
12. Kim WS, Song SY, Ahn YC, et al: CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12:349-352, 2001
13. Cheung MMC, Chan JK, Lau WH, et al: Early stage nasal T/NK-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54:182-190, 2002
14. Li YX, Gao YH, Yuan ZY, et al: Prognostic significance of international prognostic index in non-Hodgkin's lymphoma of Waldeyer's ring. Chin J Radiat Oncol 11:105-110, 2002
15. Cheung MMC, Chan JK, Lau WH, et al: Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70-77, 1998
16. Gao YH, Li YX, Yuan ZY, et al: Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil. Chin J Oncol 24:483-485, 2002
17. Zhao LJ, Li YX, Gao YH, et al: Primary non-Hodgkin's lymphoma arising in the base of tongue. Chin J Radiat Oncol 12:34-38, 2003
18. Yuan ZY, Li YX, Zhao LJ, et al: Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx. Clin J Oncol 26:425-429, 2004
19. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
20. Harris NL, Jaffe ES, Diebold J, et al: The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. Histopathology 36:69-86, 2000
21. Jaffe ES, Chan JK, Su IJ, et al: Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis and epidemiology. Am J Surg Pathol 20:103-111, 1996
22. Harabuchi Y, Imai S, Wakashima J, et al: Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies. Cancer 77:2137-2149, 1996
23. Kuo TT, Shih LY, Tsang NM: Nasal NK/T cell lymphoma in Taiwan: A clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr Virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol 12:375-387, 2004
24. Au WY, Ma SY, Chim CS, et al: Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: A single center experience of 10 years. Ann Oncol 16:206-214, 2005
25. Kim BS, Kim TY, Kim CW, et al: Therapeutic outcome of extranodal T/NK-cell lymphoma initially treated with chemotherapy: Result of chemotherapy in T/NK-cell lymphoma. Acta Oncol 42:779-783, 2003
26. Chim CS, Ma SY, Au WY, et al: Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the international prognostic index. Blood 103:216-221, 2004
27. Li CC, Tien HF, Tang JL, et al: Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 100:366-375, 2004
28. You JY, Chi KH, Yang MH, et al: Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan. Ann Oncol 15:618-625, 2004
29. Kim GE, Cho JH, Yang WI, et al: Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 18:54-63, 2000
30. Kim GE, Lee SW, Chang SK, et al: Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 61:261-269, 2001
31. Kim K, Chie EK, Kim CW, et al: Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy. Jpn J Clin Oncol 35:1-5, 2005
32. Miller TP, Dahlberg S, Cassady JR, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339:21-26, 1998
33. Horning SH, Weller E, Kim KM, et al: Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group Study 1484. J Clin Oncol 22:3032-3038, 2004
34. Aviles A, Delgado S, Ruiz H, et al: Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: Radiotherapy versus chemotherapy versus combined therapy. Eur J Cancer 32B:19-23, 1996
35. Shenkier TN, Voss N, Fairey R, et al: Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: An 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 20:197-204, 2002
36. Krol AD, Berenschot HW, Doekharan D, et al: Cyclophosphamide, doxorubicin, vincristin and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphoma: Results of a strategy that adapts radiotherapy dose to the response after chemotherapy. Radiother Oncol 58:251-255, 2001
37. Shikama N, Izuno I, Oguchi M, et al: Clinical stage IE primary lymphoma of the nasal cavity: Radiation therapy and chemotherapy. Radiology 204:467-470, 1997
38. Cheson BD, Horning SJ, Coiffier B, et al: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 17:1244-1253, 1999
39. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
40. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
41. Cox D: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
42. Shipp MA, Harrington DP, Anderson JR, et al: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
43. Shikama N, Ikeda H, Nakamura S, et al: Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: A survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 51:1228-1233, 2001
44. Yu KH, Yu SC, Teo PM, et al: Nasal lymphoma: Results of local radiotherapy with or without chemotherapy. Head Neck 19:251-259, 1997
45. Tang QL, Liu WP, Li GD, et al: Clinicopathologic features and prognostic factors of nasal and nasal-type NK/T lymphoma in South-West China. Tumor 23:411-413, 2003
46. Ng SB, Lai KW, Murugaya S, et al: Nasal-type extranodal natural killer/T-cell lymphomas: A clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 17:1097-1107, 2004
47. Altemani A, Barbosa AC, Kulka M, et al: Characteristics of nasal T/NK-cell lymphoma among Brazilians. Neoplasma 49:55-60, 2002
48. Tondini C, Zanini M, Lombardi F, et al: Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:720-725, 1993
49. Proulx GM, Caudra-Garcia I, Ferry J, et al: Lymphoma of the nasal cavity and paranasal sinuses: Treatment and outcome of early-stage disease. Am J Clin Oncol 26:6-11, 2003
50. Yong WB, Zheng W, Zhang YT, et al: Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma. Natl Med J China 81:773-775, 2001
51. Kimby E, Brandt L, Nygren P, et al: A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma. Acta Oncol 40:198-212, 2001
52. Yamaguchi M, Kita K, Miwa H, et al: Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76:2351-2356, 1995
53. Drenou B, Lamy T, Amiot L, et al: CD3-CD56+ non-Hodgkin lymphomas with an aggressive behavior related to multidrug resistance. Blood 89:2966-2974, 1997
54. Quintanilla-Martinez L, Kremer M, Keller G, et al: p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: Association with large cell morphology and advanced disease. Am J Pathol 159:2095-2105, 2001
55. Takahara M, Kishibe K, Bandoh N, et al: P53, N- and K-Ras, and β-Catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan. Hum Pathol 35:86-95, 2004
56. Li T, Hongyo T, Syaifudin M, et al: Mutations of the p53 gene in nasal T/NK-cell lymphoma. Lab Invest 80:493-499, 2000
57. Kim GE, Yang WI, Lee SW, et al: Lack of correlation between P-glycoprotein and chemotherapy resistance in nasal NK/T-cell lymphomas. Leuk Lymphoma 45:1857-1864, 2004
58. Koom WS, Chung EJ, Yang WI, et al: Angiocentric T-cell and NK/T-cell lymphomas: Radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59:1127-1137, 2004
59. Spicer J, Smith P, Maclennan K, et al: Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma. Br J Cancer 90:1151-1155, 2004
60. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al: The clinical stage I non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 69:1088-1093, 1994
61. van der Maazen RW, Noordijk EM, Thomas J, et al: Combined modality treatment is the treatment of choice for stage I/IE intermediate and high grade non-Hodgkin's lymphoma. Radiother Oncol 49:1-7, 1998
62. Wylie JP, Cowan RA, Deakin DP: The role of radiotherapy in the treatment of localized intermediate and high grade non-Hodgkin's lymphoma in elderly patients. Radiother Oncol 49:9-14, 1998
63. Wang LH, Wang WH, Huang YR, et al: Stage I non-Hodgkin's lymphoma: Treatment and prognosis. Chin J Oncol 9:14-16, 2000
64. Hayabuchi N, Shibamoto Y, Nakamura K, et al: Stage I and II aggressive B-cell lymphomas of the head and neck: Radiotherapy alone as a treatment option and the usefulness of the new prognostic index B-ALPS. Int J Radiat Oncol Biol Phys 55:44-50, 2003
65. Kaminski MS, Coleman CN, Colby TV, et al: Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med 104:747-756, 1986
66. Mok TS, Steinberg J, Chan AT, et al: Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma. Cancer 82:2439-2448, 1998